1 / 8

EpiCast Report: Diabetic Macular Edema - Epidemiology Foreca

Diabetic Macular edema (ME) occurs due to the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. In ME, fluid and protein deposits collect on or under the macula of the eye, due to a breakdown in the blood-retinal barrier. The occurrence of ME is highly frequent in diabetics and usually manifests itself as diabetic macular edema (DME). DME is often a complication of diabetic retinopathy, and is the most common cause of vision loss in individuals with diabetes, especially if left untreated. The risk for ME is high in patients with retinal vein occlusion (RVO), which consists of two types: branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). To Read Complete Report with Toc: http://www.marketresearchreports.biz/analysis/223224

Mrrbizreports
Download Presentation

EpiCast Report: Diabetic Macular Edema - Epidemiology Foreca

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EpiCastReport:Diabetic ForecastTo2023 MacularEdema-Epidemiology DiabeticMacularedema andswelling(edema)of (ME)occurs themacula, duetothethickening whichistheareaofthevision.InME,fluidandthemaculaoftheeye, retinathatisresponsibleforcentral proteindepositscollectonorunder

  2. duetoabreakdownintheblood-retinalbarrier.The occurrenceofMEishighlyfrequentindiabeticsandusuallymanifestsitselfasdiabeticmacularedema(DME).DMEisoftenacomplicationofdiabeticretinopathy,andisthemostcommoncauseofvisionlossinindividualswithdiabetes,especiallyifleftuntreated.TheriskforMEishighinpatientswithretinalveinocclusion(RVO),whichconsistsoftwotypes:branchretinalveinocclusion(BRVO)andcentralretinalveinocclusion(CRVO). ToReadCompleteReportwithToc: http://www.marketresearchreports.biz/analysis/223224

  3. GlobalDataepidemiologistsforecastthatthediagnosed prevalentcasesofDMEinthediagnoseddiabeticretinopathy populationinthe7MMwillincreaseby34.2% forecastperiod,from922,492casesin2013tocasesin2023.ThetotalprevalentcasesofME duringthe 1,238,301following BRVOinthe7MMwillincreaseby13.7%duringtheforecast period,from294,862casesin2013to335,346casesin2023. ThetotalprevalentcasesofMEfollowingCRVOinthe7MM willincreaseby19.6%duringtheforecastperiod,from 114,571casesin2013to136,973casesin2023. GlobalDatasepidemiologicalanalysisissupportedbytheuse ofcountry-specificprevalencedatafromepidemiologicalstudiespublishedinpeer-reviewedjournals.GlobalData

  4. epidemiologistsuseduniformmethodologyacrossthemarkets toforecastthediagnosedprevalentcasesofDMEinthe diagnoseddiabeticretinopathypopulationandthetotal prevalentcasesofMEfollowingBRVOandCRVO,toallow forameaningfulcomparisonofthediseasepopulationsacross markets. BrowseFullReportWithToc: http://www.marketresearchreports.biz/analysis-details/epicast-report-diabetic-macular-edema-epidemiology-forecast-to-2023

  5. Scope -TheDiabeticMacularEdema(DME)EpiCastReportprovidea anoverviewoftheriskfactors,comorbidities,andtheglobal andhistoricaltrendsforDMEinthesevenmajormarkets (7MM)(US,France,Germany,Italy,Spain,UK,andJapan). Itincludesa10-yearepidemiologicalforecastforthe diagnosedprevalentcasesofDMEinthediagnoseddiabetic retinopathypopulationandthetotalprevalentcasesofME followingbranchretinalveinocclusion(BRVO)andcentral retinalveinocclusion(CRVO)segmentedbysexandage(20- 39years,40-59years,60-79years,and=80years)inthese markets.

  6. -TheDMEepidemiologyreportiswrittenanddevelopedby Masters-andPhD-levelepidemiologists. -TheEpiCastReportisin-depth,highquality,transparent andmarket-driven,providingexpertanalysisofdiseasetrendsinthe7MM. ClickHereToDownloadDetailReport: http://www.marketresearchreports.biz/sample/sample/223224 Reasonstobuy -Developbusinessstrategiesbyunderstandingthetrends shapinganddrivingtheglobalDMEmarket.

  7. -QuantifypatientpopulationsintheglobalDMEmarketto improveproductdesign,pricing,andlaunchplans. -Organizesalesand andagegroupsthattherapeuticsineach marketingeffortsbyidentifyingthesex presentthebestopportunitiesforDME ofthemarketscovered. -IdentifythenumberofMEcasesfollowingBRVOand CRVO.

  8. ContactUS: Office:UnitedStates StateTower 90StateStreet,Suite700 Albany,NY12207 UnitedStates TollFree:866-997-4948 Tel:+1-518-618-1030 E:sales@marketresearchreports.biz

More Related